Anest. intenziv. Med. 2007;18(5):301-304

Cardiogenic shock and its current management optionsAnaesthesiology - Review articles

A. Březina, H. Říha
Klinika anesteziologie a resuscitace IKEM, Praha

A review of the causes, epidemiology, pathophysiology and treatment options of cardiogenic shock is presented.

Keywords: cardiogenic shock; pathophysiology; treatment

Published: October 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Březina A, Říha H. Cardiogenic shock and its current management options. Anest. intenziv. Med. 2007;18(5):301-304.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Goldberg, R. J., Gore, J. M., Alpert, J. S., Osganian, V., deGroot, J., Bade, J. et al. Cardiogenic shock after acute myocardial infarction. Incidence and mortality from a community-wide perspective, 1975 to 1988. N. Engl. J. Med., 1991, 325, 16, p. 1117-1122. Go to original source... Go to PubMed...
    2. Leor, J., Goldbourt, U., Reicher-Reiss, H., Kaplinsky, E., Behar, S. Cardiogenic shock complicating acute myocardial infarction in patients without heart failure on admission: incidence, risk factors, and outcome. SPRINT Study Group. Am. J. Med., 1993, 94, p. 265-273. Go to original source... Go to PubMed...
    3. McGhie, A. I., Golstein, R. A. Pathogenesis and management of acute heart failure and cardiogenic shock: role of inotropic therapy. Chest, 1992, 102, 5 Suppl. 2, p. 626-632. Go to original source... Go to PubMed...
    4. Bartling, B., Holtz, J. Darmer, D. Contribution of myocyte apoptosis to myocardial infarction? Basic Res. Cardiol., 1998, 93, p. 71-84. Go to original source... Go to PubMed...
    5. Bolli, R. Myocardial 'stunning' in man. Circulation, 1992, 86, p. 1671-1691. Go to original source... Go to PubMed...
    6. Widimský, J. a kol. Srdeční selhání. Triton, 2003, p. 71-120.
    7. Hollenberg, S. M., Kavinsky, C. J., Parrillo, J. E. Cardiogenic shock. Ann. Intern. Med., 1999, 131, 1, p. 47-59. Go to original source... Go to PubMed...
    8. Březina, A. Inotropní látky. Kardiovaskulární problematika, cyklus kurzů F.E.E.A. IPVZ, 2004, p. 106-116.
    9. Toller, W. G., Stranz, Ch. Levosimendan, a New Inotropic and Vasodilator Agent. Anesthesiology, 2006, 10, p. 556-569. Go to original source... Go to PubMed...
    10. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO Investigators. N. Engl. J. Med.,1993, 329, p. 673-682.
    11. Hasdai, D., Holmes, D. R., Califf, R. M. et al. Cardiogenic shock complicating acute myocardial infarction: predictors of death. GUSTO Investigators. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary Arteries. Am. Heart J., 1999, 138, p. 21-31. Go to original source... Go to PubMed...
    12. Barron, H. V., Every, N. R., Parsons, L. S. et al. The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction. Am. Heart J., 2001, 141, 6, p. 933-939. Go to original source... Go to PubMed...
    13. Ajani, A. E., Maruff, P., Warren, R. et al. Impact of early percutaneous coronary intervention on short- and long-term outcomes in patients with cardiogenic shock after acute myocardial infarction. Am. J. Cardiol., 2001, 87, 5, p. 633-635. Go to original source... Go to PubMed...
    14. Hochman, J. S., Boland, J., Sleeper, L. A. et al. Current spectrum of cardiogenic shock and effect of early revascularization on mortality. Results of an International Registry. SHOCK Registry Investigators. Circulation, 1995, 91, 3, p. 873-881. Go to original source... Go to PubMed...
    15. Březina, A., Říha, H., Mašín, J. Současné možnosti mechanické podpory cirkulace. Anesteziologie a intenzivní medicína, 2006, 17, 1, p. 34-37.

    Return to the content


    Anesteziologie a intenzivní medicína

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.